Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
codeine | Tablet | 15 mg (phosphate) | |
codeine | Tablet | 30 mg (phosphate) | |
morphine | Injection | 10 mg (sulfate or hydrochloride) in 1-ml ampoule | |
morphine | Oral liquid | 10 mg (hydrochloride or sulfate)/5 ml | |
morphine | Tablet (prolonged release) | 10 mg (morphine sulfate) | |
morphine | Tablet (prolonged release) | 30 mg (morphine sulfate) | |
morphine | Tablet (prolonged release) | 60 mg (morphine sulfate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amoxicillin + clavulanic acid | Tablet | 500 mg (as trihydrate) + 125 mg (as potassium salt) | |
azithromycin | Capsule | 500 mg (anhydrous) | |
azithromycin | Oral liquid | 200 mg/5 mL | |
azithromycin | Tablet | 250 mg | |
benzathine benzylpenicillin | Powder for injection | 1.44 g benzylpenicillin (= 2.4 million IU) in 5-ml vial | |
benzathine benzylpenicillin | Powder for injection | 900 mg benzylpenicillin (= 1.2 million IU) in 5-ml vial | |
benzylpenicillin | Powder for injection | 3 g (= 5 million IU) (sodium or potassium salt) in vial | |
benzylpenicillin | Powder for injection | 600 mg (= 1 million IU) (sodium or potassium salt) in vial | |
ceftazidime + avibactam | Powder for injection | 2 g + 0,5 g in vial | |
clindamycin | Capsule | 150 mg (as hydrochloride) | |
clindamycin | Injection | 150 mg (as phosphate)/mL | |
clindamycin | Oral liquid | 75 mg/5 mL (as palmitate) | |
doxycycline | Capsule | 100 mg (as hydrochloride or hyclate) | |
doxycycline | Solid oral dosage form | 100 mg (as hydrochloride or hyclate) | |
procaine benzylpenicillin | Powder for injection | 1 g (=1 million IU) in vial | |
procaine benzylpenicillin | Powder for injection | 3 g (=3 million IU) in vial | |
sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 10-mL ampoule | |
sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 5-mL ampoule | |
sulfamethoxazole + trimethoprim | Oral liquid | 200 mg + 40 mg/5 mL | |
sulfamethoxazole + trimethoprim | Tablet | 100 mg + 20 mg | |
sulfamethoxazole + trimethoprim | Tablet | 400 mg + 80 mg | |
sulfamethoxazole + trimethoprim | Tablet | 800 mg + 160 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
clofazimine | Capsule | 100 mg | |
clofazimine | Capsule | 50 mg | |
dapsone | Tablet | 100 mg | |
dapsone | Tablet | 25 mg | |
dapsone | Tablet | 50 mg | |
ofloxacin | Tablet | 400 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ethambutol | Tablet | 100 mg (hydrochloride) | |
ethambutol | Tablet | 400 mg (hydrochloride) | |
ethambutol | Tablet (dispersible) | 100 mg | |
ethambutol + isoniazid + pyrazinamide + rifampicin | Tablet | 275 mg + 75 mg + 400 mg + 150 mg | |
ethambutol + isoniazid + rifampicin | Tablet | 275 mg + 75 mg + 150 mg | |
isoniazid | Oral liquid | 50 mg/5 ml | |
isoniazid | Tablet | 300 mg | |
isoniazid | Tablet (dispersible) | 100 mg | |
isoniazid + pyrazinamide + rifampicin | Tablet | 75 mg + 400 mg + 150 mg | |
isoniazid + pyrazinamide + rifampicin | Tablet (dispersible) | 50 mg + 150 mg + 75mg | |
isoniazid + rifampicin | Tablet | 150 mg + 300 mg | |
isoniazid + rifampicin | Tablet | 75 mg + 150 mg | |
isoniazid + rifampicin | Tablet (dispersible) | 30mg + 60mg | |
isoniazid + rifampicin | Tablet (dispersible) | 50 mg + 75 mg | |
pyrazinamide | Oral liquid | 30 mg/ml | |
pyrazinamide | Tablet | 400 mg | |
pyrazinamide | Tablet (dispersible) | 150 mg | |
pyrazinamide | Tablet (scored) | 150 mg | |
rifabutin | Capsule | 150 mg | |
rifampicin | Oral liquid | 20 mg/ml | |
rifampicin | Solid oral dosage form | 150 mg | |
rifampicin | Solid oral dosage form | 300 mg | |
rifapentine | Tablet | 150 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amikacin | Powder for injection | 1 g (as sulfate) in vial | |
bedaquilina | Tablet | 100 mg | |
clofazimine | Capsule | 100 mg | |
clofazimine | Capsule | 50 mg | |
cycloserine | Solid oral dosage form | 125 mg | |
cycloserine | Solid oral dosage form | 250 mg | |
delamanid | Tablet | 50 mg | |
ethionamide | Tablet | 125 mg | |
ethionamide | Tablet | 250 mg | |
ethionamide | Tablet (dispersible) | 120 mg | |
levofloxacin | Tablet | 250 mg | |
levofloxacin | Tablet | 500 mg | |
levofloxacin | Tablet | 750 mg | |
levofloxacin | Tablet (dispersible) | 125 mg | |
linezolid | injection for intravenous administration | 2 mg/ ml | |
linezolid | Tablet | 400 mg | |
linezolid | Tablet | 600 mg | |
linezolid | Tablet (dispersible) | 150 mg | |
moxifloxacin | Tablet | 400 mg | |
moxifloxacin | Tablet (dispersible) | 100 mg | |
p-aminosalicylate sodium (PAS sodium) | Granules | 100g (60% w/w) | |
p-aminosalicylic acid | Granules | 4 g in sachet | |
protionamide | Tablet | 250 mg | |
streptomycin | Powder for injection | 1 g | |
terizidona | Capsule | 250 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amphotericin B | Powder for injection | 100 mg (lipid complex) in vial | |
amphotericin B | Powder for injection | 50 mg (sodium deoxycholate or liposomal complex) in vial | |
fluconazole | Capsule | 200 mg | |
fluconazole | Capsule | 50 mg | |
fluconazole | Injection | 2 mg/mL in vial | |
fluconazole | Oral liquid | 50 mg/5 mL | |
flucytosine | Capsule | 250 mg | |
flucytosine | Capsule | 500 mg | |
flucytosine | Infusion | 2.5 g in 250 ml | |
itraconazole | Capsule | 100 mg | |
itraconazole | Oral liquid | 10 mg/ ml | |
voriconazol | Powder for injection | 200 mg in vial | |
voriconazol | Powder for oral liquid | 40 mg/ ml | |
voriconazol | Tablet | 200 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
abacavir | Tablet | 300 mg | |
abacavir | Tablet (dispersible, scored) | 60 mg | |
abacavir + lamivudine | Tablet | 600mg + 300mg | |
abacavir + lamivudine | Tablet (dispersible, scored) | 120 mg (as sulfate) + 60 mg | |
atazanavir | Capsule | 200 mg | |
atazanavir | Capsule | 300 mg | |
atazanavir + ritonavir | Tablet | 300 mg + 100 mg | |
darunavir | Tablet | 150 mg | |
darunavir | Tablet | 400 mg | |
darunavir | Tablet | 600 mg | |
darunavir | Tablet | 75 mg | |
darunavir | Tablet | 800 mg | |
darunavir + ritonavir | Tablet | 400 mg + 50 mg | |
darunavir + ritonavir | Tablet | 600 mg + 100 mg | |
dolutegravir | Tablet | 50 mg | |
dolutegravir | Tablet (dispersible, scored) | 10 mg | |
dolutegravir + emtricitabine + tenofovir (alafenamide) | Tablet | 50mg + 200mg + 25mg | |
dolutegravir + emtricitabine + tenofovir (alafenamide) | Tablet | 50mg + 300mg + 25mg | |
dolutegravir + lamivudina + tenofovir | Tablet | 50 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate – equivalent to 245 mg tenofovir disoproxil) | |
efavirenz (EFV or EFZ) | Tablet | 600 mg | |
efavirenz (EFV or EFZ) | Tablet (scored) | 200 mg | |
efavirenz + emtricitabine + tenofovir | Tablet | 600 mg + 200 mg + 300 mg | |
efavirenz + lamivudine + tenofovir | Tablet | 400 mg + 300 mg + 300 mg | |
efavirenz + lamivudine + tenofovir | Tablet | 600 mg + 300 mg + 300 mg | |
emtricitabine + tenofovir | Tablet | 200 mg + 300 mg | |
etravirine | Tablet | 100 mg | |
etravirine | Tablet | 200 mg | |
lamivudine (3TC) | Oral liquid | 10mg/ml | |
lamivudine (3TC) | Tablet | 150 mg | |
lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
lamivudine + zidovudine | Tablet (dispersible, scored) | 30 mg + 60 mg | |
lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
lopinavir + ritonavir (LPV/r) | Solid oral dosage form | 40 mg + 10 mg | |
lopinavir + ritonavir (LPV/r) | Tablet (heat stable) | 100 mg + 25 mg | |
lopinavir + ritonavir (LPV/r) | Tablet (heat stable) | 200 mg + 50 mg | |
nevirapine (NVP) | Oral liquid | 50 mg/5 ml | |
nevirapine (NVP) | Tablet | 200 mg | |
ritonavir | Tablet (heat stable) | 100 mg | |
saquinavir (SQV) | Solid oral dosage form | 500 mg (as mesilate) | |
stavudine (d4T) | Capsule | 15 mg | |
stavudine (d4T) | Capsule | 20 mg | |
stavudine (d4T) | Capsule | 30 mg | |
stavudine (d4T) | Powder for oral liquid | 5 mg/5 ml | |
stavudine + lamivudine | Tablet | 30 mg + 150 mg | |
tenofovir + lamivudine | Capsule | 300 mg + 300 mg | |
tenofovir disoproxil fumarate | Tablet | 300 mg | |
zidovudine (ZDV or AZT) | Capsule | 100 mg | |
zidovudine (ZDV or AZT) | Oral liquid | 50 mg/5 mL | |
zidovudine (ZDV or AZT) | Solution for IV infusion injection | 10 mg/mL in 20-mL vial | |
zidovudine (ZDV or AZT) | Tablet | 300 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
aciclovir | Powder for injection | 250 mg (as sodium salt) in vial | |
aciclovir | Tablet | 200 mg | |
oseltamivir | Tablet | 75 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amphotericin B | Powder for injection | 50 mg in vial | |
meglumine antimoniate | Solution for IV infusion injection | 85 mg/ml in ampoule | |
paromomycin | Solution for intramuscular injection | 750 mg of paromomycin base (as the sulfate) | |
pentamidine | Tablet | 200 mg (as isethionate) | |
pentamidine | Tablet | 300 mg (as isethionate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amodiaquine | Tablet | 153 mg (as hydrochloride) | |
amodiaquine | Tablet | 200 mg (as hydrochloride) | |
artemether | Oily injection | 80 mg/ml in 1-ml ampoule | |
artemether + lumefantrine | Tablet | 20 mg + 120 mg | |
artesunate | Injection | ampoules, containing 60 mg anhydrous artesunic acid with a separate ampoule of 5% sodium bicarbonate solution | |
artesunate | Rectal dosage form | 200 mg capsules | |
artesunate | Tablet | 50 mg | |
artesunate + amodiaquine | Tablet | 100 mg + 270 mg | |
artesunate + amodiaquine | Tablet | 25 mg + 67.5 mg | |
artesunate + amodiaquine | Tablet | 50 mg + 135 mg | |
artesunate + mefloquine | Tablet | 100 mg + 220 mg | |
atovaquone + proguanil | Tablet | 250 mg + 100 mg (as hydrochloride) | |
atovaquone + proguanil | Tablet | 62.5 mg + 25 mg (as hydrochloride) | c2 |
chloroquine | Oral liquid | 50 mg (as phosphate or sulfate)/5 ml | |
chloroquine | Tablet | 100 mg (as phosphate or sulfate) | |
chloroquine | Tablet | 150 mg (as phosphate or sulfate) | |
mefloquine | Tablet | 250 mg (hydrochloride) | |
primaquine | Tablet | 15 mg (as diphosphate) | |
primaquine | Tablet | 7.5 mg (as diphosphate) | |
proguanil | Tablet | 100 mg (as hydrochloride) | |
quinine | Injection | 300 mg quinine hydrochloride/mL in 2-mL ampoule | |
quinine | Tablet | 300 mg (quinine bisulfate) | |
quinine | Tablet | 300 mg (quinine sulfate) | |
sulfadoxine + pyrimethamine | Tablet | 500 mg + 25 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
pentamidine | Tablet | 200 mg (as isethionate) | |
pentamidine | Tablet | 300 mg (as isethionate) | |
pyrimethamine | Tablet | 25 mg | |
sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 10-mL ampoule | |
sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 5-mL ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
benznidazole | Tablet | 100 mg | |
nifurtimox | Tablet | 120 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
albendazole | Tablet (chewable) | 400 mg | |
mebendazole | Tablet (chewable) | 500 mg | |
niclosamide | Tablet (chewable) | 500 mg | |
praziquantel | Tablet | 150 mg | |
praziquantel | Tablet | 600 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
triclabendazole | Tablet | 250 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
diethylcarbamazine | Tablet | 100 mg (dihydrogen citrate) | |
diethylcarbamazine | Tablet | 50 mg (dihydrogen citrate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
azathioprine | Powder for injection | 100 mg (as sodium salt) in vial | |
azithromycin | Powder for oral suspension | 200 mg | |
ciclosporin | Capsule | 25 mg | |
ciclosporin | Concentrate for injection | 50 mg/ml in 1-ml ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
asparaginase | Powder for injection | 10 000 IU in vial | |
bleomycin | Powder for injection | 15 mg (as sulfate) in vial | |
calcium folinate | Injection | 3 mg/mL in 10-mL ampoule | |
calcium folinate | Tablet | 15 mg | |
chlorambucil | Tablet | 2 mg | |
cisplatin | Powder for injection | 10 mg in vial | |
cisplatin | Powder for injection | 50 mg in vial | |
cyclophosphamide | Powder for injection | 500 mg in vial | |
cyclophosphamide | Tablet | 25 mg | |
cytarabine | Powder for injection | 100 mg in vial | |
dacarbazine | Powder for injection | 100 mg in vial | |
dactinomycin | Powder for injection | 500 mcg in vial | |
daunorubicin | Powder for injection | 50 mg (hydrochloride) in vial | |
doxorubicin | Powder for injection | 10 mg (hydrochloride) in vial | |
doxorubicin | Powder for injection | 50 mg (hydrochloride) in vial | |
etoposide | Capsule | 100 mg | |
etoposide | Injection | 20 mg/mL in 5-mL ampoule | |
mercaptopurine | Tablet | 50 mg | |
mesna | Injectable solution | 400 mg | |
methotrexate | Powder for injection | 50 mg (as sodium salt) in vial | |
methotrexate | Tablet | 2.5 mg (as sodium salt) | |
procarbazine | Capsule | 50 mg (as hydrochloride) | |
tamoxifen | Tablet | 10 mg (as citrate) | |
tamoxifen | Tablet | 20 mg (as citrate) | |
vinblastine | Powder for injection | 10 mg (sulfate) in vial | |
vincristine | Powder for injection | 1 mg (sulfate) in vial | |
vincristine | Powder for injection | 5 mg (sulfate) in vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
factor IX complex (coagulation factors, II, VII, IX, X) concentrate | Dried | N/A | |
factor VIII concentrate | Dried | N/A | |
human normal immunoglobulin | Intramuscular administration | 16% protein solution | |
human normal immunoglobulin | Intravenous administration | 10% protein solution | |
human normal immunoglobulin | Intravenous administration | 5% protein solution |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
anti-D immunoglobulin (human) | Injection | 250 mcg in single-dose vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amlodipine | Tablet | 5 mg (as maleate, mesylate or besylate) | |
bisoprolol | Tablet | 1.25 mg | |
bisoprolol | Tablet | 5 mg | |
carvedilol | Tablet | 12.5 mg | |
carvedilol | Tablet | 25 mg | |
carvedilol | Tablet | 3.125 mg | |
carvedilol | Tablet | 50 mg | |
carvedilol | Tablet | 6.25 mg | |
chlorthalidone | Tablet | 12.5 mg | |
chlorthalidone | Tablet | 25 mg | |
hydralazine | Powder for injection | 20 mg (hydrochloride) in ampoule | |
hydralazine | Tablet | 25 mg (hydrochloride) | |
hydralazine | Tablet | 50 mg (hydrochloride) | |
sodium nitroprusside | Powder for infusion | 50 mg in ampoule | |
surfactant | Suspension for intratracheal instillation | 25 mg/ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
glyceryl trinitrate | Tablet (sublingual) | 500 mcg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
streptokinase | Powder for injection | 1.5 million IU in vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amidotrizoate | Injection | 140 mg to 420 mg iodine (as sodium or meglumine salt)/ml in 20-ml ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ethinylestradiol + levonorgestrel | Tablet | 30 mcg + 150 mcg | |
ethinylestradiol + norethisterone | Tablet | 35 micrograms + 1 mg | |
levonorgestrel | Tablet | 1.5 mg | |
levonorgestrel | Tablet | 30 micrograms | |
levonorgestrel | Tablet | 750 micrograms (pack of two) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
estradiol cypionate + medroxyprogesterone acetate | Injection | 5 mg + 25 mg | |
medroxyprogesterone acetate | Depot injection | 150 mg/mL in 1-mL vial | |
norethisterone enantate | Oily solution | 200 mg/ml in 1-ml ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
insulin injection (soluble) | Injection | 40 IU/ml in 10-ml vial | |
intermediate-acting insulin | Injection | 100 IU/ml in 10-ml vial | |
intermediate-acting insulin | Injection | 100 IU/ml in 10-ml vial | |
intermediate-acting insulin | Injection | 40 IU/ml in 10-ml vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
recombinant human erytropoietin | Injection | 20 000-50 000 UI/ml | |
recombinant human erytropoietin | Injection | 2000-5000 UI/ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
dexamethasone | Injection | 4 mg/mL in 1-mL ampoule (as disodium phosphate salt) | |
hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
alcuronium | Injection | 5 mg (chloride)/ml in 2ml ampoule | |
vecuronium | Powder for injection | 10 mg (bromide)/mL in ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
carbamazepine | Oral liquid | 100 mg/5 ml | |
carbamazepine | Tablet (chewable) | 100 mg | |
carbamazepine | Tablet (chewable) | 200 mg | |
carbamazepine | Tablet (scored) | 100 mg | |
carbamazepine | Tablet (scored) | 200 mg | |
diazepam | Injection | 5 mg/mL | |
diazepam | Rectal solution | 5 mg/mL in 2-mL tubes | |
ergometrine | Injection | 0.2 mg/mL (maleate) in 1-mL ampoule | |
magnesium sulfate | Injection | 500 mg/mL in 10-mL ampoule | |
magnesium sulfate | Injection | 500 mg/mL in 2-mL ampoule | |
mifepristone | Tablet | 200 mg | |
mifepristone + misoprostol | Tablet | 200 mg + 200 micrograms | |
misoprostol | Tablet | 200 mcg | |
oxytocin | Injection | 10 IU in 1-mL ampoule | |
phenobarbital | Injection | 200 mg/mL (sodium) | |
phenobarbital | Oral liquid | 15 mg/5 mL | |
phenobarbital | Tablet | 15 mg to 100 mg | |
phenytoin | Injection | 50 mg/mL in 5-mL vial (sodium salt) | |
phenytoin | Oral liquid | 25 mg to 30 mg/5 mL | |
phenytoin | Solid oral dosage form | 100 mg (sodium salt) | |
phenytoin | Solid oral dosage form | 25 mg (sodium salt) | |
phenytoin | Solid oral dosage form | 50 mg (sodium salt) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
chlorpromazine | Injection | 25 mg (hydrochloride)/mL in 2-mL ampoule | |
chlorpromazine | Oral liquid | 25 mg (hydrochloride)/5 mL | |
chlorpromazine | Tablet | 100 mg (hydrochloride) | |
fluphenazine | Injection | 25 mg (decanoate or enantate) in 1-mL ampoule | |
haloperidol | Injection | 5 mg/mL in 1-mL ampoule | |
haloperidol | Tablet | 2 mg | |
haloperidol | Tablet | 5 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amitriptyline | Tablet | 25 mg (hydrochloride) | |
fluoxetine | Solid oral dosage form | 20 mg (as hydrochloride) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
lithium carbonate | Solid oral dosage form | 300 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
calcium gluconate | Injection | 100 mg/mL in 10-mL ampoule |